Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Conditions: Multiple Endocrine Neoplasia; Recurrent Thyroid Cancer; Thyroid Gland Medullary CarcinomaInterventions: Drug: sorafenib tosylate; Other: pharmacological study; Other: laboratory biomarker analysisSponsor: National Cancer Institute (NCI)Active, not recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Multiple Endocrine Neoplasia | Multiple Endocrine Neoplasia Syndrome | Research | Study | Thyroid | Thyroid Cancer